SynBioBeta Speaker
Imad Ajjawi
CEO
RyboDyn
May 2026, SynBioBeta
Speaker
Imad Ajjawi, PhD, MBA is a biotechnology entrepreneur and leader in AI-enabled drug discovery, currently serving as Co-Founder and CEO of RyboDyn. His work focuses on unlocking previously inaccessible biology, including the dark transcriptome and dark proteome, to enable the discovery of novel therapeutic targets.Prior to RyboDyn, Imad founded Denovium, an AI-driven protein discovery and design company acquired by Absci, which subsequently went public at a $1.5 billion valuation. During his tenure, he secured more than $100 million through strategic partnerships, venture financing, and M&A.Imad has authored more than 25 patents and peer-reviewed publications spanning synthetic biology, computational biology, and protein engineering. His work has been featured in leading media outlets including WIRED, Forbes, Bloomberg, and NPR.At RyboDyn, Imad is advancing a new paradigm for therapeutic discovery by integrating novel sequencing technologies with AI-driven bioinformatics to systematically identify and validate cryptic, disease-specific targets across oncology and other therapeutic areas.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.